Mirvie

Mirvie is a clinical-stage women's health company founded in 2018 and based in South San Francisco, California, pioneering the early prediction of pregnancy complications. Its proprietary RNA platform uses a simple maternal blood test and machine learning to read tens of thousands of molecular messages from mother, baby, and placenta, revealing the underlying biology of each pregnancy months before symptoms appear. Mirvie's first product, the Encompass preeclampsia test, pairs a novel blood test that predicts personalized preeclampsia risk with a preventive care plan and received FDA Breakthrough Device designation. The company is backed by General Catalyst, GV, Mayfield, Khosla Ventures, Foresite Capital, and Decheng Capital. Mirvie operates consumer and clinical web properties (mirvie.com and encompasstest.com) but publishes no public developer API; this profile captures its identity and domain-security posture for the API Evangelist network.

Mirvie is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Women’s Health, Prenatal, and Pregnancy.

Mirvie’s developer surface includes engineering blog, support, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
15.0/100 emerging ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyHealthcareWomen's HealthPrenatalPregnancyDiagnosticsBiotechnologyRNAPreeclampsia

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 15.0/100 · emerging
Contract Quality 0.0 / 25
Developer Ergonomics 1.3 / 20
Commercial Clarity 4.2 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/mirvie: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Mirvie Domain Security

TLSv1.3 · HSTS · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support
Support

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy
 TermsOfService
TermsOfService

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: mirvie
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/mirvie.png
name: Mirvie
description: Mirvie is a clinical-stage women's health company founded in 2018 and based in South San Francisco, California,
  pioneering the early prediction of pregnancy complications. Its proprietary RNA platform uses a simple maternal blood test
  and machine learning to read tens of thousands of molecular messages from mother, baby, and placenta, revealing the underlying
  biology of each pregnancy months before symptoms appear. Mirvie's first product, the Encompass preeclampsia test, pairs
  a novel blood test that predicts personalized preeclampsia risk with a preventive care plan and received FDA Breakthrough
  Device designation. The company is backed by General Catalyst, GV, Mayfield, Khosla Ventures, Foresite Capital, and Decheng
  Capital. Mirvie operates consumer and clinical web properties (mirvie.com and encompasstest.com) but publishes no public
  developer API; this profile captures its identity and domain-security posture for the API Evangelist network.
url: https://raw.githubusercontent.com/api-evangelist/mirvie/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- general-catalyst
- gv
- mayfield
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Healthcare
- Women's Health
- Prenatal
- Pregnancy
- Diagnostics
- Biotechnology
- RNA
- Preeclampsia
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.mirvie.com
- type: Blog
  url: https://www.mirvie.com/mirvie-media-releases
- type: Support
  url: https://www.mirvie.com/get-in-touch
- type: PrivacyPolicy
  url: https://www.mirvie.com/privacy-policy
- type: TermsOfService
  url: https://www.mirvie.com/terms-of-service
- type: DomainSecurity
  url: security/mirvie-domain-security.yml
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1